Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ET-blockade and Exercise-induced Vascular Adaptations in T2DM

This study has been completed.
Sponsor:
Collaborator:
Actelion
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT01779609
First received: January 28, 2013
Last updated: May 4, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):